MARKETS / NASDAQ / NDSN

NASDAQ · GENERAL INDUSTRIAL MACHINERY & EQUIPMENT, NEC · LARGE CAP

Nordson Corp. NDSN

18 fiscal years on record · USD · FY2025 reported · SEC filings only

16 YEARS OF DIVIDEND GROWTH

Revenue

$2.8B

▲ 3.8% YoY

Net income

$484.5M

▲ 3.7% YoY

Free cash flow

$661.1M

▲ 34.4% YoY

In brief

What this company does

Nordson Corporation engineers, manufactures and markets products and systems used for precision dispensing, applying and controlling of adhesives, coatings, polymers, sealants, biomaterials and other fluids, to test and inspect for quality, and to treat and cure surfaces and various medical products such as catheters, cannulas, medical balloons and medical tubing. It markets its products through a network of direct operations in more than 35 countries. As of October 31, 2025, it had approximately 8,000 employees worldwide. The Industrial Precision Solutions segment delivers dispensing and material processing technology to diverse end markets. The Medical and Fluid Solutions segment includes components and device solutions for medical, life science, high-tech industrial and other diverse end markets. The Advanced Technology Solutions segment integrates the company's proprietary product technologies into the progressive stages of a customer's production processes, including surface treatment, precisely controlled dispensing of material, and pre- and post-dispense test and inspection. Nordson Corporation was incorporated in the State of Ohio in 1954 and is headquartered in Westlake, Ohio.

Written from the business description in NORDSON CORPORATION's annual report to the U.S. Securities and Exchange Commission, filed 17 December 2025. Every sentence was checked against that document before publication.

Growth

USD 2.8B

Revenue, FY2025 · full 18-year series below

Revenue $B Net income $B

FY2025 · Revenue 2.8 · Net income 0.5

Compound annual growth

Revenue

+2.5%

+5.6%

+5.2%

+6.8%

Net income

−1.9%

+14.2%

+8.7%

+7.3%

EPS, diluted

−1.1%

+14.8%

+9.4%

+8.6%

Dividend / share

+13.2%

+15.6%

+13.4%

+15.0%

Returned to shareholders

+8.1%

+39.5%

+1.0%

+18.5%

3 yrs

5 yrs

10 yrs

15 yrs

Revenue compounded at +5.6% a year over five years — but profit grew faster: net income at +14.2%, earnings per share at +14.8%.

The share count fell from 0.06B to 0.06B — the buyback concentrates the same profit into fewer slices.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

17 cents

of every revenue dollar became profit

Operating margin Net margin

FY2025 · Operating 25.5% · Net 17.4%

ROE

FY2025 · ROE 16.2%

Gross margin55.2%

Operating margin25.5%

Net margin17.4%

Return on assets8.1%

EBITDAUSD 791.0M

Each USD of equity produced 16 cents of profit this year.

Cash & shareholders

USD 476.4M

returned in FY2025 · dividends + net buybacks

Free cash flow $M

FY2025 · FCF 661.1

Net buybacks $M Dividends $M

FY2025 · Dividends 179.1 · Net buybacks 297.4

Dividends paidUSD 179.1M

Net buybacksUSD 297.4M

Share of profit98.3%

Consecutive raises16 years (since the 2009 share-count change)

USD 179.1M in dividends and USD 297.4M in buybacks — 98% of the year's profit went back to shareholders.

Total assetsUSD 5.9B

EquityUSD 3.0B

CashUSD 108.4M

Gross debtUSD 2.0B

Net debtUSD 1.9B

Current ratio1.64×

Net debt stands at 62% of equity.

The 18-year record

18 fiscal years

Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
Revenue $B	2.8	2.7	2.6	2.6	2.4	2.1	2.2	2.3	2.1	1.8	1.7	1.7	1.5	1.4	1.2	1.0	0.8	1.1
Operating income $B	0.7	0.7	0.7	0.7	0.6	0.3	0.5	0.5	0.5	0.4	0.3	0.4	0.3	0.3	0.3	0.2	−0.1	0.2
EBITDA $B	0.8	0.8	0.7	0.8	0.7	0.4	0.5	0.6	0.5	0.4	0.4	0.4	0.4	0.4	0.3	0.3	−0.1	0.2
Income tax $B	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1
Net income $B	0.5	0.5	0.5	0.5	0.5	0.2	0.3	0.4	0.3	0.3	0.2	0.2	0.2	0.2	0.2	0.2	−0.2	0.1
Free cash flow $B	0.7	0.5	0.6	0.5	0.5	0.5	0.3	0.4	0.3	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.1
EPS, diluted $	8.51	8.11	8.46	8.81	7.74	4.27	5.79	6.40	5.08	4.73	3.45	3.84	3.42	3.45	3.25	2.46	−2.38	3.43
Dividend / sh $	3.16	2.82	2.63	2.18	1.69	1.53	1.43	1.25	1.11	0.99	0.90	0.76	0.63	0.53	0.44	0.39	0.37	0.73
Payout %	37	35	31	25	21	35	24	19	22	21	26	20	18	15	13	16	−15	21
ROE %	16.2	16.9	19.9	23.0	23.2	14.9	22.2	29.0	29.5	36.0	27.0	27.5	28.5	36.2	41.3	38.4	−33.9	20.5
Shares out B	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.07	0.07	·	·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance

Company facts, as filed

How we verify · 0 failures in 70 reconciliationsAUDITED

Reconciled in 18 of 19 fiscal years. 7 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures

ActivityGeneral Industrial Machinery & Equipment, NEC

Listed onNASDAQ

Incorporated inOhio

Fiscal year endsOctober 31

Data on record since2008